tirzepatide patent expiry in india just opened the floodgates for “Ozempic-like” drugs. With the of Semaglutide, what was once expensive and out of reach is now becoming far more accessible across the country. A Semaglutide patent expiry in India
Description
How to Spot a Fake or Misleading GLP-1 Product Protect your health and your wallet by looking for these red flags: It's Available for Purchase Now: Since no GLP-1 patch is currently FDA-approved, anything you can buy today is not a legitimate medical product
Compounding pharmacies create these formulations under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act

This reflects obesity as a chronic metabolic condition rather than an acute problem that resolves permanently
For a broader comparison of compounded vs branded GLP-1 options, see our detailed semaglutide vs tirzepatide comparison and our guide on compounded semaglutide

It has practical implications for whether your supply continues uninterrupted and whether the medication you receive is being produced legally

(2023) 278:e7605
